Original Article
The Impact of Alternative Treatment for Abnormal Uterine Bleeding on Hysterectomy Rates in a Tertiary Referral Center

https://doi.org/10.1016/j.jmig.2008.09.608Get rights and content

Abstract

Study Objective

The purpose of this study was to estimate the influence of alternatives to hysterectomy for abnormal uterine bleeding (AUB) on hysterectomy rates.

Design

Retrospective cohort study. Canadian Task Force II-2.

Setting

University hospital.

Patients

Premenopausal patients with AUB.

Interventions

Medical records of all premenopausal patients treated for AUB in our university clinic between January 1, 1995, and December 31, 2004, were reviewed. Patients were identified based on (specific) diagnostic and therapy codes used in the registry system of the hospital. The total number of placements of levonorgestrel-releasing intrauterine device (LNG-IUD), hysteroscopic surgery, and hysterectomies performed/year was estimated. In addition, the course of treatment of each patient was assessed.

Measurements and Main Results

A total of 640 patients received surgery and 246 LNG-IUDs were placed. The proportion of endometrial ablations decreased significantly over time (p <.001), whereas hysteroscopic polyp or myoma removal (p =.030) and insertion of LNG-IUD (p <.001) both increased. The proportion of patients receiving hysterectomy for AUB as their first therapy decreased significantly (p =.005) from 40.6% to 31.4%, although the total number of patients receiving hysterectomy remained similar (p =.449). The 5-year intervention-free percentage for LNG-IUD was 70.6% (SD = 3.3%), for hysteroscopic polyp or myoma removal 75.5% (SD = 3.3%), and for endometrial ablation 78.0% (SD = 4.3%; p =.067).

Conclusion

Despite the introduction of alternative therapies, the total hysterectomy rate in the management of AUB did not decrease in our clinic.

Section snippets

Material and Methods

Medical records of all premenopausal patients receiving surgery or LNG-IUD because of abnormal uterine bleeding between January 1, 1995, and December 31, 2004, were reviewed. Abnormal uterine bleeding was defined as menorrhagia, metrorrhagia, or intermenstrual bleeding. Patients were excluded in case of infertility, postmenopausal state, or (suggestion of) malignancy of the genital tract.

Eligible patients were identified based on (specific) diagnostic codes (e.g., for menorrhagia, metrorrhagia,

Results

In the investigated period, 2157 premenopausal patients with AUB attended our clinic. Of this group, 1271 (58.9%) patients received oral medical therapy or no treatment at all; the other 886 (41.1%) patients had either surgical therapy or received LNG-IUD. Within this time frame, staffing remained similar (staffing performing hysterectomy [n = 6] and endoscopic surgery [n = 3]).

Patient characteristics are detailed in Table 1. The mean age at which LNG-IUD (41.6 years) was placed and

Discussion

Even though several alternative treatment modalities were developed to date, the overall hysterectomy rate in the management of AUB did not decrease in our clinic during the years (1995–2004) reviewed in this study. The numbers of hysteroscopic surgeries and insertion of LNG-IUD as alternative treatment for this indication increased. On the contrary, the number of women receiving endometrial ablation declined. A probable explanation for this decline is the replacement by LNG-IUD, introduced in

Conclusion

In our clinic, the hysterectomy rate in the management of AUB did not decrease, despite the introduction of alternative therapies. An explanation to this phenomenon remains speculative, although to assure adequate implementation of alternative therapies it is of great importance to determine, at least nationwide and preferably internationally, its real impact on costs and satisfaction.

References (16)

There are more references available in the full text version of this article.

Cited by (20)

  • Expulsion rates of the levonorgestrel 52 mg intrauterine system are similar among women with heavy menstrual bleeding and users for contraception

    2022, Contraception
    Citation Excerpt :

    In 2015, this device was approved by the US Food and Drug Administration [5] and in more than 100 countries as a contraceptive method and as a medical treatment for heavy menstrual bleeding. Its use has been associated with a reduction in some medical and surgical treatments, such as use of tranexamic acid, oral progestins, endometrial ablation, and hysterectomy [6-9]. The LNG IUS is recommended as a first-line treatment in women with nonstructural heavy menstrual bleeding [10,11].

  • Nationwide trends in the utilization of and payments for hysterectomy in the United States among commercially insured women

    2018, American Journal of Obstetrics and Gynecology
    Citation Excerpt :

    This may be due to the increased use of endometrial ablation and progesterone eluting intrauterine devices to control bothersome abnormal bleeding and chronic pelvic pain. These therapies have enabled many premenopausal women to control symptoms without resorting to invasive, extirpative surgery.10 The number of hysterectomies for pelvic organ prolapse also decreased 19.4%.

  • Temporal trend and nationwide utility for hysterectomies in Taiwan, 1997–2010

    2016, Taiwanese Journal of Obstetrics and Gynecology
    Citation Excerpt :

    Similar to most surgeries, hysterectomy causes a negative impact on the quality of life. Although a number of less invasive alternative therapies have been developed to replace hysterectomy [9], hysterectomy remains the second most common gynecological surgery in the United States [1]. In this study, we observed that the rate of hysterectomy varied from country to country [3].

  • Hysterectomy

    2013, Women and Health
  • The trends of minimally invasive surgery for benign gynecologic lesions, 1997-2007 in Taiwan

    2012, Gynecology and Minimally Invasive Therapy
    Citation Excerpt :

    Laparoscopy is indicated for benign uterine lesions including uterine myoma and adenomyosis, intractable pelvic pain, severe abnormal uterine bleeding, and poor response to medical treatment. The nonsurgical alternative treatments for benign uterine conditions have been developed to be first-line therapy, including levonorgestrel-releasing intrauterine device, hysteroscopic polyp or myoma removal, and endometrial ablation.13 However, the influence of these procedures on hysterectomy rates currently remains uncertain, due to the lack of long-term research studies that aim to identify the effectiveness of various treatment methods.12

  • Hysterectomy

    2012, Women and Health, Second Edition
View all citing articles on Scopus

The authors have no commercial, proprietary, or financial interest in the products or companies described in this article.

View full text